<DOC>
	<DOC>NCT00351052</DOC>
	<brief_summary>This study will investigate the steroid sparing effect of pimecrolimus cream 1% in pediatric atopic dermatitis</brief_summary>
	<brief_title>Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Outpatients aged 2 to &lt; 18 years with severe AD (score 8 or 9 according to Rajka and Langeland) responded to 21 days of treatment with prednicarbate cream 0.25% during screening phase Patients who had received phototherapy, systemic or topical therapy or systemic corticosteroids shortly prior to study</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Pimecrolimus, Atopic Dermatitis, Eczema, Pediatric</keyword>
</DOC>